
Aditi Dutt
Examiner (ID: 13235, Phone: (571)272-9037 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1675, 1649 |
| Total Applications | 615 |
| Issued Applications | 219 |
| Pending Applications | 75 |
| Abandoned Applications | 327 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12367392
[patent_doc_number] => 09957332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-01
[patent_title] => Compositions and methods for treating cocaine-related disorders
[patent_app_type] => utility
[patent_app_number] => 14/208597
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10860
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14208597
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/208597 | Compositions and methods for treating cocaine-related disorders | Mar 12, 2014 | Issued |
Array
(
[id] => 10954615
[patent_doc_number] => 20140357638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-04
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/191984
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11634
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14191984
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/191984 | COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE | Feb 26, 2014 | Abandoned |
Array
(
[id] => 10435823
[patent_doc_number] => 20150320835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'MANIPULATION OF HAIRY AND ENHANCER OF SPLIT 3 (HES3) AND ITS REGULATORS/MEDIATORS AS A NEW ANTI-CANCER STRATEGY'
[patent_app_type] => utility
[patent_app_number] => 14/653744
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17563
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653744
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/653744 | Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy | Dec 19, 2013 | Issued |
Array
(
[id] => 10414642
[patent_doc_number] => 20150299652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'COMPOSITIONS AND METHODS FOR GENERATING NEURAL CREST STEM CELLS AND SENSORY NEURONS'
[patent_app_type] => utility
[patent_app_number] => 14/648190
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19272
[patent_no_of_claims] => 96
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648190
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/648190 | COMPOSITIONS AND METHODS FOR GENERATING NEURAL CREST STEM CELLS AND SENSORY NEURONS | Nov 26, 2013 | Abandoned |
Array
(
[id] => 9656227
[patent_doc_number] => 20140227232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'Methods and Compositions for Delivery of Exogenous Factors to Nervous System Sites'
[patent_app_type] => utility
[patent_app_number] => 14/078329
[patent_app_country] => US
[patent_app_date] => 2013-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20140
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14078329
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/078329 | Methods and compositions for delivery of exogenous factors to nervous system sites | Nov 11, 2013 | Issued |
Array
(
[id] => 11016807
[patent_doc_number] => 20160213760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-28
[patent_title] => 'APROTININ-DERIVED POLYPEPTIDE-ANTIBODY CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 14/442091
[patent_app_country] => US
[patent_app_date] => 2013-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17184
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442091
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442091 | APROTININ-DERIVED POLYPEPTIDE-ANTIBODY CONJUGATES | Nov 11, 2013 | Abandoned |
Array
(
[id] => 9944210
[patent_doc_number] => 08993510
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-31
[patent_title] => 'Peptides and methods using same for diagnosis and treatment of amyloid-associated disease'
[patent_app_type] => utility
[patent_app_number] => 13/975414
[patent_app_country] => US
[patent_app_date] => 2013-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 134
[patent_no_of_words] => 31957
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13975414
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/975414 | Peptides and methods using same for diagnosis and treatment of amyloid-associated disease | Aug 25, 2013 | Issued |
Array
(
[id] => 9382517
[patent_doc_number] => 20140085998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'COMPOSITION COMPRISING VARIOUS PROTEORHODOPSINS AND/OR BACTERIORHODOPSINS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/974988
[patent_app_country] => US
[patent_app_date] => 2013-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9318
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13974988
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/974988 | COMPOSITION COMPRISING VARIOUS PROTEORHODOPSINS AND/OR BACTERIORHODOPSINS AND USE THEREOF | Aug 22, 2013 | Abandoned |
Array
(
[id] => 9269680
[patent_doc_number] => 20140024599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATMENT OF DISEASE OR INJURY OF THE NERVOUS SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 13/946419
[patent_app_country] => US
[patent_app_date] => 2013-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12840
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13946419
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/946419 | Methods and compositions for treatment of disease or injury of the nervous system | Jul 18, 2013 | Issued |
Array
(
[id] => 11303674
[patent_doc_number] => 09511055
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Angiotensin in treating brain conditions'
[patent_app_type] => utility
[patent_app_number] => 13/897051
[patent_app_country] => US
[patent_app_date] => 2013-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21008
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13897051
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/897051 | Angiotensin in treating brain conditions | May 16, 2013 | Issued |
Array
(
[id] => 11799641
[patent_doc_number] => 09540432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-10
[patent_title] => 'Anti-Aβ globulomer 7C6 antibodies'
[patent_app_type] => utility
[patent_app_number] => 13/893780
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 11
[patent_no_of_words] => 45965
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893780
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/893780 | Anti-Aβ globulomer 7C6 antibodies | May 13, 2013 | Issued |
Array
(
[id] => 9339592
[patent_doc_number] => 20140066374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity'
[patent_app_type] => utility
[patent_app_number] => 13/887722
[patent_app_country] => US
[patent_app_date] => 2013-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9457
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887722
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/887722 | Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity | May 5, 2013 | Abandoned |
Array
(
[id] => 9081056
[patent_doc_number] => 20130266586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'Method of Providing Disease-Specific Binding Molecules and Targets'
[patent_app_type] => utility
[patent_app_number] => 13/841485
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 43402
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13841485
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/841485 | Method of Providing Disease-Specific Binding Molecules and Targets | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9080985
[patent_doc_number] => 20130266514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'Method of Providing Disease-Specific Binding Molecules and Targets'
[patent_app_type] => utility
[patent_app_number] => 13/838526
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 43423
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13838526
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/838526 | Method of Providing Disease-Specific Binding Molecules and Targets | Mar 14, 2013 | Abandoned |
Array
(
[id] => 9197676
[patent_doc_number] => 20130336991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'Sp35 Antibodies and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/841351
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 55594
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13841351
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/841351 | Sp35 antibodies and uses thereof | Mar 14, 2013 | Issued |
Array
(
[id] => 9081055
[patent_doc_number] => 20130266585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'Method of Providing Disease-Specific Binding Molecules and Targets'
[patent_app_type] => utility
[patent_app_number] => 13/827673
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 43408
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13827673
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/827673 | Method of Providing Disease-Specific Binding Molecules and Targets | Mar 13, 2013 | Abandoned |
Array
(
[id] => 9175122
[patent_doc_number] => 20130317107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'Platelet-Based Methods to Detect and Monitor Treatment Benefits in Mucosal and Nervous Systems Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/800051
[patent_app_country] => US
[patent_app_date] => 2013-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 24057
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13800051
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/800051 | Platelet-Based Methods to Detect and Monitor Treatment Benefits in Mucosal and Nervous Systems Diseases | Mar 12, 2013 | |
Array
(
[id] => 9477269
[patent_doc_number] => 20140134732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'Simplified Compositions and Methods for Generating Neural Stem Cells From Human Pluripotent Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 13/795485
[patent_app_country] => US
[patent_app_date] => 2013-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 10051
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13795485
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/795485 | Simplified Compositions and Methods for Generating Neural Stem Cells From Human Pluripotent Stem Cells | Mar 11, 2013 | Abandoned |
Array
(
[id] => 8990705
[patent_doc_number] => 20130217986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'METHOD AND SYSTEM FOR PREDICTING AN AMYLOIDOSIS STATUS'
[patent_app_type] => utility
[patent_app_number] => 13/772600
[patent_app_country] => US
[patent_app_date] => 2013-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7624
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13772600
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/772600 | METHOD AND SYSTEM FOR PREDICTING AN AMYLOIDOSIS STATUS | Feb 20, 2013 | Abandoned |
Array
(
[id] => 9227489
[patent_doc_number] => 08633158
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-01-21
[patent_title] => 'Angiotensin in treating brain conditions'
[patent_app_type] => utility
[patent_app_number] => 13/752202
[patent_app_country] => US
[patent_app_date] => 2013-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20984
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13752202
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/752202 | Angiotensin in treating brain conditions | Jan 27, 2013 | Issued |